A Phase I/II Open Label Study in MPS IIIB Subjects to In

Project: Research project

Project Details

Description

A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
StatusFinished
Effective start/end date1/15/1512/31/18

Funding

  • SYNAGEVA BIOPHARMA CORP.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.